TP53 and cancer: Based on KEGG pathway enrichment analysis, our data further reveal that various oncogenic pathways with significant roles in the pathology of PDAC are significantly enriched for the selected common targets, including cancer, hepatitis B, apoptosis, p53 signaling, and PI3K/Akt signaling pathways.